PetDx

PetDx™ is an innovative molecular diagnostics company, founded by highly experienced cancer researchers and veterinarians who are harnessing the power of genomics to develop a first-of-its-kind test for the detection, characterization, and management of canine cancer, based on a simple blood draw. Its cutting-edge approach to the science will radically change how cancer is managed in dogs, so they can enjoy longer, healthier lives with their humans.